Venture Capital

Europe is flush with scale-up cash but struggles to create giants. A new data-driven initiative in Slovenia aims to solve this, but is it enough?

As global VCs retreat, Canada's tech startups are more reliant on US funding than ever. Is this a life raft or a strategic risk for the nation's future?

With wins from the Cerebras and SpaceX IPOs, Open Doors Partners hires Ravi Chiruvolu to deepen its expertise in a pivotal moment for private markets.

The iconic business publisher joins Mercurius Media Capital, trading ad space for startup equity in a move that could redefine venture funding for a new era.

A new class of athlete is trading endorsements for equity. The addition of MLB stars Jon Jay and Tyson Ross to BrknPar Ventures isn't just a headline—it's a sign of a fundamental shift in venture capital.

MDB Capital celebrates a string of successful IPOs but reports a staggering $16.1M loss, putting its unique 'public venture' model under intense scrutiny.

While venture fundraising slows, GEM oversubscribes its new seed fund. Brian Nelson analyzes how the firm is leveraging market fragmentation to back the next wave of innovators.

Joe Benevento's C-Suite award is more than a trophy; it's a marker for Virginia's stunning rise as a tech hub. We dig into the numbers and strategy.

Amid market shifts, Northern 3 VCT posts strong NAV growth. A deep dive reveals a dual strategy: investing in AI pioneers and cashing in on past wins.

As AI reshapes the threat landscape, VC firm Costanoa brings in ex-Uber and Meta CSO Joe Sullivan. A look at why operational expertise is the new currency in cybersecurity investing.

A team of medtech veterans, fresh off a $585M exit to Medtronic, just launched NovoMed PARTNERS. Their operator-led model could rewrite the rules.

JumpStart VC Fest is more than a conference. It's a strategic engine designed to funnel capital and talent into the Midwest, challenging Silicon Valley's grip.

Novartis's acquisition of Myricx Bio isn't just a deal. It's a story of academic grit, venture capital vision, and a new blueprint for patient-centric cancer therapy.

Beyond software, a new breed of venture capital is funding America's industrial rebirth, pouring millions into AI, robotics, and the factories of the future.

Balerion Space Ventures' hire of a top engineer signals a major shift. In deep tech, the sharpest minds are no longer just building—they're investing.

A new corporate venture fund by Pegasus Tech Ventures and Japan's Asteria Corp. isn't just about capital; it's a strategic bridge to redefine global innovation.

The world's only lupus-focused fund is betting on a new model blending VC rigor with patient-led strategy. But can this ambitious structure deliver real progress?

Forget the crypto hype. A top VC's success with IPOs and acquisitions reveals a quieter, more profound shift towards a mature, value-driven Web3.

With a new $155M fund, Larsen Jensen's firm is arming deep tech startups to win the next geopolitical race, blending military strategy with venture capital.

With a focus on AI, deepfake detection, and core infrastructure, the latest Sanabil Accelerator cohort reveals a strategic bet on regional resilience and global scale.